nodes	percent_of_prediction	percent_of_DWPC	metapath
Amiloride—PLAU—Beta5 beta6 beta7 and beta8 integrin cell surface interactions—EDIL3—ankylosing spondylitis	0.104	0.141	CbGpPWpGaD
Amiloride—ASIC2—Stimuli-sensing channels—ANO6—ankylosing spondylitis	0.0518	0.0704	CbGpPWpGaD
Amiloride—PLAU—Beta3 integrin cell surface interactions—EDIL3—ankylosing spondylitis	0.0493	0.0671	CbGpPWpGaD
Amiloride—SCNN1G—Stimuli-sensing channels—ANO6—ankylosing spondylitis	0.0392	0.0534	CbGpPWpGaD
Amiloride—SCNN1A—Stimuli-sensing channels—ANO6—ankylosing spondylitis	0.0392	0.0534	CbGpPWpGaD
Amiloride—ASIC1—Stimuli-sensing channels—ANO6—ankylosing spondylitis	0.0392	0.0534	CbGpPWpGaD
Amiloride—SCNN1B—Stimuli-sensing channels—ANO6—ankylosing spondylitis	0.0392	0.0534	CbGpPWpGaD
Amiloride—SCNN1D—Stimuli-sensing channels—ANO6—ankylosing spondylitis	0.0392	0.0534	CbGpPWpGaD
Amiloride—ASIC2—Ion channel transport—ANO6—ankylosing spondylitis	0.0338	0.046	CbGpPWpGaD
Amiloride—PLAU—Senescence and Autophagy in Cancer—CREG1—ankylosing spondylitis	0.0284	0.0387	CbGpPWpGaD
Amiloride—SCNN1G—Ion channel transport—ANO6—ankylosing spondylitis	0.0256	0.0348	CbGpPWpGaD
Amiloride—SCNN1D—Ion channel transport—ANO6—ankylosing spondylitis	0.0256	0.0348	CbGpPWpGaD
Amiloride—ASIC1—Ion channel transport—ANO6—ankylosing spondylitis	0.0256	0.0348	CbGpPWpGaD
Amiloride—SCNN1B—Ion channel transport—ANO6—ankylosing spondylitis	0.0256	0.0348	CbGpPWpGaD
Amiloride—SCNN1A—Ion channel transport—ANO6—ankylosing spondylitis	0.0256	0.0348	CbGpPWpGaD
Amiloride—PLAU—Endochondral Ossification—RUNX3—ankylosing spondylitis	0.0133	0.0181	CbGpPWpGaD
Amiloride—PLAU—Beta2 integrin cell surface interactions—CD40LG—ankylosing spondylitis	0.0124	0.0168	CbGpPWpGaD
Amiloride—ASIC2—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.0118	0.016	CbGpPWpGaD
Amiloride—PLAU—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—MMP3—ankylosing spondylitis	0.00978	0.0133	CbGpPWpGaD
Amiloride—SLC9A1—Defective B3GAT3 causes JDSSDHD—B3GNT2—ankylosing spondylitis	0.00965	0.0131	CbGpPWpGaD
Amiloride—ASIC1—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.00891	0.0121	CbGpPWpGaD
Amiloride—SCNN1A—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.00891	0.0121	CbGpPWpGaD
Amiloride—SCNN1G—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.00891	0.0121	CbGpPWpGaD
Amiloride—SCNN1B—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.00891	0.0121	CbGpPWpGaD
Amiloride—SCNN1D—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.00891	0.0121	CbGpPWpGaD
Amiloride—Blood potassium increased—Prednisone—ankylosing spondylitis	0.00664	0.0278	CcSEcCtD
Amiloride—Intraocular pressure increased—Prednisolone—ankylosing spondylitis	0.00627	0.0262	CcSEcCtD
Amiloride—PLAU—AP-1 transcription factor network—IL10—ankylosing spondylitis	0.00611	0.00831	CbGpPWpGaD
Amiloride—SLC9A1—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.00587	0.00799	CbGpPWpGaD
Amiloride—Intraocular pressure increased—Triamcinolone—ankylosing spondylitis	0.00577	0.0241	CcSEcCtD
Amiloride—Intraocular pressure increased—Methylprednisolone—ankylosing spondylitis	0.00576	0.0241	CcSEcCtD
Amiloride—PLAU—AP-1 transcription factor network—HLA-A—ankylosing spondylitis	0.00538	0.00732	CbGpPWpGaD
Amiloride—Intraocular pressure increased—Dexamethasone—ankylosing spondylitis	0.00523	0.0219	CcSEcCtD
Amiloride—Intraocular pressure increased—Betamethasone—ankylosing spondylitis	0.00523	0.0219	CcSEcCtD
Amiloride—SLC9A1—Carbohydrate metabolism—B3GNT2—ankylosing spondylitis	0.00518	0.00705	CbGpPWpGaD
Amiloride—Intraocular pressure increased—Prednisone—ankylosing spondylitis	0.00456	0.0191	CcSEcCtD
Amiloride—PLAU—Senescence and Autophagy in Cancer—IL1A—ankylosing spondylitis	0.00444	0.00604	CbGpPWpGaD
Amiloride—PLAU—amb2 Integrin signaling—TNF—ankylosing spondylitis	0.00435	0.00592	CbGpPWpGaD
Amiloride—Peptic ulcer—Prednisolone—ankylosing spondylitis	0.00413	0.0173	CcSEcCtD
Amiloride—Peptic ulcer—Triamcinolone—ankylosing spondylitis	0.0038	0.0159	CcSEcCtD
Amiloride—Peptic ulcer—Methylprednisolone—ankylosing spondylitis	0.00379	0.0158	CcSEcCtD
Amiloride—Peptic ulcer—Betamethasone—ankylosing spondylitis	0.00344	0.0144	CcSEcCtD
Amiloride—Peptic ulcer—Dexamethasone—ankylosing spondylitis	0.00344	0.0144	CcSEcCtD
Amiloride—Peptic ulcer—Prednisone—ankylosing spondylitis	0.003	0.0125	CcSEcCtD
Amiloride—PLAU—Betamethasone—Methylprednisolone—ankylosing spondylitis	0.00274	0.105	CbGdCrCtD
Amiloride—PLAU—Dexamethasone—Methylprednisolone—ankylosing spondylitis	0.00274	0.105	CbGdCrCtD
Amiloride—PLAU—Betamethasone—Dexamethasone—ankylosing spondylitis	0.0027	0.104	CbGdCrCtD
Amiloride—PLAU—Dexamethasone—Betamethasone—ankylosing spondylitis	0.0027	0.104	CbGdCrCtD
Amiloride—SLC22A4—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.00269	0.00366	CbGpPWpGaD
Amiloride—PLAU—Betamethasone—Triamcinolone—ankylosing spondylitis	0.00263	0.101	CbGdCrCtD
Amiloride—PLAU—Dexamethasone—Triamcinolone—ankylosing spondylitis	0.00263	0.101	CbGdCrCtD
Amiloride—Encephalopathy—Methotrexate—ankylosing spondylitis	0.00261	0.0109	CcSEcCtD
Amiloride—PLAU—Dexamethasone—Prednisone—ankylosing spondylitis	0.0025	0.0961	CbGdCrCtD
Amiloride—PLAU—Betamethasone—Prednisone—ankylosing spondylitis	0.0025	0.0961	CbGdCrCtD
Amiloride—SLC9A1—Disease—ANTXR2—ankylosing spondylitis	0.00249	0.00339	CbGpPWpGaD
Amiloride—Liver disorder—Methotrexate—ankylosing spondylitis	0.00246	0.0103	CcSEcCtD
Amiloride—PLAU—Betamethasone—Prednisolone—ankylosing spondylitis	0.00244	0.0938	CbGdCrCtD
Amiloride—PLAU—Dexamethasone—Prednisolone—ankylosing spondylitis	0.00244	0.0938	CbGdCrCtD
Amiloride—Visual disturbance—Prednisolone—ankylosing spondylitis	0.00211	0.00884	CcSEcCtD
Amiloride—Hyperuricaemia—Methotrexate—ankylosing spondylitis	0.00181	0.00756	CcSEcCtD
Amiloride—Muscular weakness—Prednisolone—ankylosing spondylitis	0.00177	0.00739	CcSEcCtD
Amiloride—Visual disturbance—Betamethasone—ankylosing spondylitis	0.00176	0.00738	CcSEcCtD
Amiloride—Visual disturbance—Dexamethasone—ankylosing spondylitis	0.00176	0.00738	CcSEcCtD
Amiloride—Abdominal distension—Prednisolone—ankylosing spondylitis	0.00174	0.00729	CcSEcCtD
Amiloride—Blood uric acid increased—Methotrexate—ankylosing spondylitis	0.00171	0.00714	CcSEcCtD
Amiloride—Muscular weakness—Triamcinolone—ankylosing spondylitis	0.00162	0.0068	CcSEcCtD
Amiloride—Muscular weakness—Methylprednisolone—ankylosing spondylitis	0.00162	0.00678	CcSEcCtD
Amiloride—Abdominal distension—Triamcinolone—ankylosing spondylitis	0.0016	0.00671	CcSEcCtD
Amiloride—Abdominal distension—Methylprednisolone—ankylosing spondylitis	0.0016	0.00669	CcSEcCtD
Amiloride—Aplastic anaemia—Methotrexate—ankylosing spondylitis	0.00157	0.00658	CcSEcCtD
Amiloride—Coma—Methotrexate—ankylosing spondylitis	0.00153	0.00641	CcSEcCtD
Amiloride—Urine output increased—Methotrexate—ankylosing spondylitis	0.00151	0.00634	CcSEcCtD
Amiloride—Gynaecomastia—Methotrexate—ankylosing spondylitis	0.0015	0.00627	CcSEcCtD
Amiloride—Muscular weakness—Dexamethasone—ankylosing spondylitis	0.00147	0.00617	CcSEcCtD
Amiloride—Muscular weakness—Betamethasone—ankylosing spondylitis	0.00147	0.00617	CcSEcCtD
Amiloride—SLC9A1—Disease—B3GNT2—ankylosing spondylitis	0.00147	0.002	CbGpPWpGaD
Amiloride—Gastrointestinal haemorrhage—Prednisone—ankylosing spondylitis	0.00146	0.00609	CcSEcCtD
Amiloride—Bradycardia—Prednisolone—ankylosing spondylitis	0.00141	0.0059	CcSEcCtD
Amiloride—Haemoglobin—Prednisolone—ankylosing spondylitis	0.00139	0.00583	CcSEcCtD
Amiloride—Haemorrhage—Prednisolone—ankylosing spondylitis	0.00139	0.0058	CcSEcCtD
Amiloride—Polyuria—Methotrexate—ankylosing spondylitis	0.00139	0.0058	CcSEcCtD
Amiloride—Visual impairment—Prednisolone—ankylosing spondylitis	0.00134	0.00559	CcSEcCtD
Amiloride—Bradycardia—Triamcinolone—ankylosing spondylitis	0.0013	0.00543	CcSEcCtD
Amiloride—Bradycardia—Methylprednisolone—ankylosing spondylitis	0.00129	0.00542	CcSEcCtD
Amiloride—Muscular weakness—Prednisone—ankylosing spondylitis	0.00128	0.00537	CcSEcCtD
Amiloride—Visual disturbance—Methotrexate—ankylosing spondylitis	0.00128	0.00537	CcSEcCtD
Amiloride—Haemoglobin—Triamcinolone—ankylosing spondylitis	0.00128	0.00536	CcSEcCtD
Amiloride—Haemoglobin—Methylprednisolone—ankylosing spondylitis	0.00128	0.00535	CcSEcCtD
Amiloride—Haemorrhage—Triamcinolone—ankylosing spondylitis	0.00127	0.00533	CcSEcCtD
Amiloride—Haemorrhage—Methylprednisolone—ankylosing spondylitis	0.00127	0.00532	CcSEcCtD
Amiloride—SLC22A2—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.00127	0.00173	CbGpPWpGaD
Amiloride—Abdominal distension—Prednisone—ankylosing spondylitis	0.00127	0.0053	CcSEcCtD
Amiloride—SLC9A1—Metabolism—B3GNT2—ankylosing spondylitis	0.00123	0.00167	CbGpPWpGaD
Amiloride—Visual impairment—Methylprednisolone—ankylosing spondylitis	0.00123	0.00513	CcSEcCtD
Amiloride—SLC22A1—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.00118	0.00161	CbGpPWpGaD
Amiloride—Bradycardia—Betamethasone—ankylosing spondylitis	0.00118	0.00492	CcSEcCtD
Amiloride—Bradycardia—Dexamethasone—ankylosing spondylitis	0.00118	0.00492	CcSEcCtD
Amiloride—Neutropenia—Prednisone—ankylosing spondylitis	0.00118	0.00492	CcSEcCtD
Amiloride—Haemoglobin—Betamethasone—ankylosing spondylitis	0.00116	0.00486	CcSEcCtD
Amiloride—Haemoglobin—Dexamethasone—ankylosing spondylitis	0.00116	0.00486	CcSEcCtD
Amiloride—Erectile dysfunction—Prednisone—ankylosing spondylitis	0.00116	0.00485	CcSEcCtD
Amiloride—Haemorrhage—Betamethasone—ankylosing spondylitis	0.00116	0.00484	CcSEcCtD
Amiloride—Haemorrhage—Dexamethasone—ankylosing spondylitis	0.00116	0.00484	CcSEcCtD
Amiloride—Depression—Prednisone—ankylosing spondylitis	0.00112	0.00468	CcSEcCtD
Amiloride—Visual impairment—Betamethasone—ankylosing spondylitis	0.00111	0.00466	CcSEcCtD
Amiloride—Visual impairment—Dexamethasone—ankylosing spondylitis	0.00111	0.00466	CcSEcCtD
Amiloride—Vertigo—Prednisolone—ankylosing spondylitis	0.00108	0.00453	CcSEcCtD
Amiloride—Back pain—Triamcinolone—ankylosing spondylitis	0.00107	0.00449	CcSEcCtD
Amiloride—Bradycardia—Prednisone—ankylosing spondylitis	0.00102	0.00429	CcSEcCtD
Amiloride—Alopecia—Dexamethasone—ankylosing spondylitis	0.00102	0.00427	CcSEcCtD
Amiloride—Alopecia—Betamethasone—ankylosing spondylitis	0.00102	0.00427	CcSEcCtD
Amiloride—Haemoglobin—Prednisone—ankylosing spondylitis	0.00101	0.00423	CcSEcCtD
Amiloride—Haemorrhage—Prednisone—ankylosing spondylitis	0.00101	0.00421	CcSEcCtD
Amiloride—Vertigo—Triamcinolone—ankylosing spondylitis	0.000997	0.00417	CcSEcCtD
Amiloride—Vertigo—Methylprednisolone—ankylosing spondylitis	0.000994	0.00416	CcSEcCtD
Amiloride—Neutropenia—Methotrexate—ankylosing spondylitis	0.000983	0.00411	CcSEcCtD
Amiloride—Dysuria—Methotrexate—ankylosing spondylitis	0.000983	0.00411	CcSEcCtD
Amiloride—Shock—Prednisolone—ankylosing spondylitis	0.000968	0.00405	CcSEcCtD
Amiloride—Erectile dysfunction—Methotrexate—ankylosing spondylitis	0.000968	0.00405	CcSEcCtD
Amiloride—Cough—Triamcinolone—ankylosing spondylitis	0.000968	0.00405	CcSEcCtD
Amiloride—Arthralgia—Methylprednisolone—ankylosing spondylitis	0.000942	0.00394	CcSEcCtD
Amiloride—Depression—Methotrexate—ankylosing spondylitis	0.000935	0.00391	CcSEcCtD
Amiloride—Confusional state—Methylprednisolone—ankylosing spondylitis	0.000911	0.00381	CcSEcCtD
Amiloride—Vertigo—Dexamethasone—ankylosing spondylitis	0.000904	0.00378	CcSEcCtD
Amiloride—Vertigo—Betamethasone—ankylosing spondylitis	0.000904	0.00378	CcSEcCtD
Amiloride—Shock—Triamcinolone—ankylosing spondylitis	0.000891	0.00373	CcSEcCtD
Amiloride—Insomnia—Prednisolone—ankylosing spondylitis	0.00089	0.00373	CcSEcCtD
Amiloride—Alopecia—Prednisone—ankylosing spondylitis	0.00089	0.00372	CcSEcCtD
Amiloride—Shock—Methylprednisolone—ankylosing spondylitis	0.000889	0.00372	CcSEcCtD
Amiloride—Paraesthesia—Prednisolone—ankylosing spondylitis	0.000884	0.0037	CcSEcCtD
Amiloride—Haemoglobin—Methotrexate—ankylosing spondylitis	0.000846	0.00354	CcSEcCtD
Amiloride—Pain—Prednisolone—ankylosing spondylitis	0.000842	0.00352	CcSEcCtD
Amiloride—Haemorrhage—Methotrexate—ankylosing spondylitis	0.000841	0.00352	CcSEcCtD
Amiloride—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.000825	0.00345	CcSEcCtD
Amiloride—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.000823	0.00344	CcSEcCtD
Amiloride—Insomnia—Triamcinolone—ankylosing spondylitis	0.000819	0.00343	CcSEcCtD
Amiloride—Insomnia—Methylprednisolone—ankylosing spondylitis	0.000817	0.00342	CcSEcCtD
Amiloride—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.000813	0.0034	CcSEcCtD
Amiloride—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.000811	0.00339	CcSEcCtD
Amiloride—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.000811	0.00339	CcSEcCtD
Amiloride—Visual impairment—Methotrexate—ankylosing spondylitis	0.000811	0.00339	CcSEcCtD
Amiloride—Shock—Dexamethasone—ankylosing spondylitis	0.000808	0.00338	CcSEcCtD
Amiloride—Shock—Betamethasone—ankylosing spondylitis	0.000808	0.00338	CcSEcCtD
Amiloride—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.000807	0.00338	CcSEcCtD
Amiloride—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.000797	0.00333	CcSEcCtD
Amiloride—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.000795	0.00333	CcSEcCtD
Amiloride—Vertigo—Prednisone—ankylosing spondylitis	0.000787	0.00329	CcSEcCtD
Amiloride—Tinnitus—Methotrexate—ankylosing spondylitis	0.000785	0.00328	CcSEcCtD
Amiloride—Anorexia—Dexamethasone—ankylosing spondylitis	0.000783	0.00328	CcSEcCtD
Amiloride—Anorexia—Betamethasone—ankylosing spondylitis	0.000783	0.00328	CcSEcCtD
Amiloride—Fatigue—Triamcinolone—ankylosing spondylitis	0.00078	0.00327	CcSEcCtD
Amiloride—Fatigue—Methylprednisolone—ankylosing spondylitis	0.000779	0.00326	CcSEcCtD
Amiloride—Pain—Triamcinolone—ankylosing spondylitis	0.000774	0.00324	CcSEcCtD
Amiloride—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.000748	0.00313	CcSEcCtD
Amiloride—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.000748	0.00313	CcSEcCtD
Amiloride—Arthralgia—Prednisone—ankylosing spondylitis	0.000746	0.00312	CcSEcCtD
Amiloride—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.000746	0.00312	CcSEcCtD
Amiloride—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.000744	0.00311	CcSEcCtD
Amiloride—Alopecia—Methotrexate—ankylosing spondylitis	0.000744	0.00311	CcSEcCtD
Amiloride—Insomnia—Dexamethasone—ankylosing spondylitis	0.000743	0.00311	CcSEcCtD
Amiloride—Insomnia—Betamethasone—ankylosing spondylitis	0.000743	0.00311	CcSEcCtD
Amiloride—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.000739	0.00309	CcSEcCtD
Amiloride—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.000738	0.00309	CcSEcCtD
Amiloride—Paraesthesia—Betamethasone—ankylosing spondylitis	0.000738	0.00309	CcSEcCtD
Amiloride—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.000723	0.00303	CcSEcCtD
Amiloride—Dyspepsia—Betamethasone—ankylosing spondylitis	0.000723	0.00303	CcSEcCtD
Amiloride—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.000714	0.00299	CcSEcCtD
Amiloride—Decreased appetite—Betamethasone—ankylosing spondylitis	0.000714	0.00299	CcSEcCtD
Amiloride—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.000714	0.00299	CcSEcCtD
Amiloride—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.000709	0.00297	CcSEcCtD
Amiloride—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.000709	0.00297	CcSEcCtD
Amiloride—Back pain—Methotrexate—ankylosing spondylitis	0.000709	0.00296	CcSEcCtD
Amiloride—Fatigue—Betamethasone—ankylosing spondylitis	0.000708	0.00296	CcSEcCtD
Amiloride—Fatigue—Dexamethasone—ankylosing spondylitis	0.000708	0.00296	CcSEcCtD
Amiloride—Shock—Prednisone—ankylosing spondylitis	0.000704	0.00294	CcSEcCtD
Amiloride—Pain—Betamethasone—ankylosing spondylitis	0.000702	0.00294	CcSEcCtD
Amiloride—Pain—Dexamethasone—ankylosing spondylitis	0.000702	0.00294	CcSEcCtD
Amiloride—Anorexia—Prednisone—ankylosing spondylitis	0.000682	0.00285	CcSEcCtD
Amiloride—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.000677	0.00283	CcSEcCtD
Amiloride—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.000677	0.00283	CcSEcCtD
Amiloride—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.000672	0.00281	CcSEcCtD
Amiloride—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.000672	0.00281	CcSEcCtD
Amiloride—Vertigo—Methotrexate—ankylosing spondylitis	0.000658	0.00275	CcSEcCtD
Amiloride—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.000652	0.00273	CcSEcCtD
Amiloride—Dizziness—Prednisolone—ankylosing spondylitis	0.000651	0.00272	CcSEcCtD
Amiloride—Asthenia—Triamcinolone—ankylosing spondylitis	0.000649	0.00272	CcSEcCtD
Amiloride—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.000649	0.00272	CcSEcCtD
Amiloride—Abdominal pain—Betamethasone—ankylosing spondylitis	0.000649	0.00272	CcSEcCtD
Amiloride—Asthenia—Methylprednisolone—ankylosing spondylitis	0.000648	0.00271	CcSEcCtD
Amiloride—Insomnia—Prednisone—ankylosing spondylitis	0.000647	0.00271	CcSEcCtD
Amiloride—Paraesthesia—Prednisone—ankylosing spondylitis	0.000642	0.00269	CcSEcCtD
Amiloride—Pruritus—Triamcinolone—ankylosing spondylitis	0.00064	0.00268	CcSEcCtD
Amiloride—Cough—Methotrexate—ankylosing spondylitis	0.000639	0.00267	CcSEcCtD
Amiloride—Pruritus—Methylprednisolone—ankylosing spondylitis	0.000639	0.00267	CcSEcCtD
Amiloride—Dyspepsia—Prednisone—ankylosing spondylitis	0.00063	0.00263	CcSEcCtD
Amiloride—Chest pain—Methotrexate—ankylosing spondylitis	0.000624	0.00261	CcSEcCtD
Amiloride—Arthralgia—Methotrexate—ankylosing spondylitis	0.000624	0.00261	CcSEcCtD
Amiloride—Decreased appetite—Prednisone—ankylosing spondylitis	0.000622	0.0026	CcSEcCtD
Amiloride—Rash—Prednisolone—ankylosing spondylitis	0.000621	0.0026	CcSEcCtD
Amiloride—Dermatitis—Prednisolone—ankylosing spondylitis	0.00062	0.00259	CcSEcCtD
Amiloride—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.000618	0.00259	CcSEcCtD
Amiloride—Fatigue—Prednisone—ankylosing spondylitis	0.000617	0.00258	CcSEcCtD
Amiloride—Headache—Prednisolone—ankylosing spondylitis	0.000617	0.00258	CcSEcCtD
Amiloride—Constipation—Prednisone—ankylosing spondylitis	0.000612	0.00256	CcSEcCtD
Amiloride—Confusional state—Methotrexate—ankylosing spondylitis	0.000603	0.00252	CcSEcCtD
Amiloride—Dizziness—Triamcinolone—ankylosing spondylitis	0.000599	0.0025	CcSEcCtD
Amiloride—Dizziness—Methylprednisolone—ankylosing spondylitis	0.000597	0.0025	CcSEcCtD
Amiloride—SLC9A1—Disease—HLA-A—ankylosing spondylitis	0.000594	0.000808	CbGpPWpGaD
Amiloride—Feeling abnormal—Prednisone—ankylosing spondylitis	0.000589	0.00247	CcSEcCtD
Amiloride—Asthenia—Betamethasone—ankylosing spondylitis	0.000589	0.00247	CcSEcCtD
Amiloride—Asthenia—Dexamethasone—ankylosing spondylitis	0.000589	0.00247	CcSEcCtD
Amiloride—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.000585	0.00245	CcSEcCtD
Amiloride—Nausea—Prednisolone—ankylosing spondylitis	0.000585	0.00245	CcSEcCtD
Amiloride—Pruritus—Dexamethasone—ankylosing spondylitis	0.000581	0.00243	CcSEcCtD
Amiloride—Pruritus—Betamethasone—ankylosing spondylitis	0.000581	0.00243	CcSEcCtD
Amiloride—Vomiting—Triamcinolone—ankylosing spondylitis	0.000576	0.00241	CcSEcCtD
Amiloride—Vomiting—Methylprednisolone—ankylosing spondylitis	0.000574	0.0024	CcSEcCtD
Amiloride—Rash—Triamcinolone—ankylosing spondylitis	0.000571	0.00239	CcSEcCtD
Amiloride—Dermatitis—Triamcinolone—ankylosing spondylitis	0.00057	0.00239	CcSEcCtD
Amiloride—Anorexia—Methotrexate—ankylosing spondylitis	0.00057	0.00238	CcSEcCtD
Amiloride—Rash—Methylprednisolone—ankylosing spondylitis	0.00057	0.00238	CcSEcCtD
Amiloride—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000569	0.00238	CcSEcCtD
Amiloride—Headache—Triamcinolone—ankylosing spondylitis	0.000567	0.00237	CcSEcCtD
Amiloride—Headache—Methylprednisolone—ankylosing spondylitis	0.000566	0.00237	CcSEcCtD
Amiloride—Abdominal pain—Prednisone—ankylosing spondylitis	0.000565	0.00237	CcSEcCtD
Amiloride—Diarrhoea—Betamethasone—ankylosing spondylitis	0.000562	0.00235	CcSEcCtD
Amiloride—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.000562	0.00235	CcSEcCtD
Amiloride—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.000545	0.00228	CcSEcCtD
Amiloride—Dizziness—Dexamethasone—ankylosing spondylitis	0.000543	0.00227	CcSEcCtD
Amiloride—Dizziness—Betamethasone—ankylosing spondylitis	0.000543	0.00227	CcSEcCtD
Amiloride—Insomnia—Methotrexate—ankylosing spondylitis	0.000541	0.00226	CcSEcCtD
Amiloride—Nausea—Triamcinolone—ankylosing spondylitis	0.000538	0.00225	CcSEcCtD
Amiloride—Paraesthesia—Methotrexate—ankylosing spondylitis	0.000537	0.00225	CcSEcCtD
Amiloride—Nausea—Methylprednisolone—ankylosing spondylitis	0.000537	0.00224	CcSEcCtD
Amiloride—Dyspnoea—Methotrexate—ankylosing spondylitis	0.000533	0.00223	CcSEcCtD
Amiloride—Somnolence—Methotrexate—ankylosing spondylitis	0.000531	0.00222	CcSEcCtD
Amiloride—Dyspepsia—Methotrexate—ankylosing spondylitis	0.000526	0.0022	CcSEcCtD
Amiloride—Vomiting—Betamethasone—ankylosing spondylitis	0.000522	0.00219	CcSEcCtD
Amiloride—Vomiting—Dexamethasone—ankylosing spondylitis	0.000522	0.00219	CcSEcCtD
Amiloride—Decreased appetite—Methotrexate—ankylosing spondylitis	0.00052	0.00217	CcSEcCtD
Amiloride—Rash—Dexamethasone—ankylosing spondylitis	0.000518	0.00217	CcSEcCtD
Amiloride—Rash—Betamethasone—ankylosing spondylitis	0.000518	0.00217	CcSEcCtD
Amiloride—Dermatitis—Betamethasone—ankylosing spondylitis	0.000517	0.00216	CcSEcCtD
Amiloride—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000517	0.00216	CcSEcCtD
Amiloride—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.000516	0.00216	CcSEcCtD
Amiloride—Fatigue—Methotrexate—ankylosing spondylitis	0.000515	0.00216	CcSEcCtD
Amiloride—Headache—Dexamethasone—ankylosing spondylitis	0.000515	0.00215	CcSEcCtD
Amiloride—Headache—Betamethasone—ankylosing spondylitis	0.000515	0.00215	CcSEcCtD
Amiloride—Asthenia—Prednisone—ankylosing spondylitis	0.000513	0.00215	CcSEcCtD
Amiloride—Pain—Methotrexate—ankylosing spondylitis	0.000511	0.00214	CcSEcCtD
Amiloride—Pruritus—Prednisone—ankylosing spondylitis	0.000506	0.00212	CcSEcCtD
Amiloride—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.000493	0.00206	CcSEcCtD
Amiloride—Diarrhoea—Prednisone—ankylosing spondylitis	0.000489	0.00205	CcSEcCtD
Amiloride—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.000489	0.00205	CcSEcCtD
Amiloride—Nausea—Dexamethasone—ankylosing spondylitis	0.000488	0.00204	CcSEcCtD
Amiloride—Nausea—Betamethasone—ankylosing spondylitis	0.000488	0.00204	CcSEcCtD
Amiloride—Dizziness—Prednisone—ankylosing spondylitis	0.000473	0.00198	CcSEcCtD
Amiloride—Abdominal pain—Methotrexate—ankylosing spondylitis	0.000473	0.00198	CcSEcCtD
Amiloride—Vomiting—Prednisone—ankylosing spondylitis	0.000455	0.0019	CcSEcCtD
Amiloride—Rash—Prednisone—ankylosing spondylitis	0.000451	0.00189	CcSEcCtD
Amiloride—Dermatitis—Prednisone—ankylosing spondylitis	0.000451	0.00189	CcSEcCtD
Amiloride—Headache—Prednisone—ankylosing spondylitis	0.000448	0.00187	CcSEcCtD
Amiloride—Asthenia—Methotrexate—ankylosing spondylitis	0.000429	0.00179	CcSEcCtD
Amiloride—Nausea—Prednisone—ankylosing spondylitis	0.000425	0.00178	CcSEcCtD
Amiloride—Pruritus—Methotrexate—ankylosing spondylitis	0.000423	0.00177	CcSEcCtD
Amiloride—Diarrhoea—Methotrexate—ankylosing spondylitis	0.000409	0.00171	CcSEcCtD
Amiloride—Dizziness—Methotrexate—ankylosing spondylitis	0.000395	0.00165	CcSEcCtD
Amiloride—Vomiting—Methotrexate—ankylosing spondylitis	0.00038	0.00159	CcSEcCtD
Amiloride—Rash—Methotrexate—ankylosing spondylitis	0.000377	0.00158	CcSEcCtD
Amiloride—Dermatitis—Methotrexate—ankylosing spondylitis	0.000377	0.00158	CcSEcCtD
Amiloride—Headache—Methotrexate—ankylosing spondylitis	0.000375	0.00157	CcSEcCtD
Amiloride—Nausea—Methotrexate—ankylosing spondylitis	0.000355	0.00149	CcSEcCtD
Amiloride—SLC22A2—Metabolism—B3GNT2—ankylosing spondylitis	0.000266	0.000362	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—B3GNT2—ankylosing spondylitis	0.000248	0.000337	CbGpPWpGaD
